Understanding the rise of cardiometabolic diseases in low- and middle-income countries
- PMID: 31700182
- DOI: 10.1038/s41591-019-0644-7
Understanding the rise of cardiometabolic diseases in low- and middle-income countries
Abstract
Increases in the prevalence of noncommunicable diseases (NCDs), particularly cardiometabolic diseases such as cardiovascular disease, stroke and diabetes, and their major risk factors have not been uniform across settings: for example, cardiovascular disease mortality has declined over recent decades in high-income countries but increased in low- and middle-income countries (LMICs). The factors contributing to this rise are varied and are influenced by environmental, social, political and commercial determinants of health, among other factors. This Review focuses on understanding the rise of cardiometabolic diseases in LMICs, with particular emphasis on obesity and its drivers, together with broader environmental and macro determinants of health, as well as LMIC-based responses to counteract cardiometabolic diseases.
References
-
- Horton, R. Offline: time to radically rethink non-communicable diseases. Lancet 393, 1922 (2019). - PubMed
-
- Nugent, R. & Fottrell, E. Non-communicable diseases and climate change: linked global emergencies. Lancet 394, 622–623 (2019).
-
- Bloom, D.E. et al. The Global Economic Burden of Noncommunicable Diseases (World Economic Forum, 2011).
-
- Kelland, K. Chronic disease to cost $47 trillion by 2030: WEF. Reuters (18 September 2011).
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
